Advanced Oncology Certified Nurse Practitioner (AOCNP) Certification Practice Test 2025 - Free AOCNP Practice Questions and Study Guide

Androgen deprivation therapy (ADT) is specifically designed to lower androgen levels, particularly testosterone, in prostate cancer patients. Prostate cancer growth is often fueled by androgens, and by reducing these hormone levels, ADT can help slow the progression of the disease and enhance the effectiveness of other treatments. This approach can be achieved through medications that inhibit testosterone production or block its effects on cancer cells, addressing the hormonal component essential to managing prostate cancer effectively.

Other treatment options listed, such as chemotherapy and radiation therapy, focus on killing cancer cells or damaging their DNA but do not target androgen levels directly. Immunotherapy employs the patient’s immune system to fight cancer but also does not have a specific action on androgens. Therefore, ADT is the primary treatment option among the choices for specifically lowering androgen levels in patients with prostate cancer, making it the correct choice.